NGNE · ISSUER CIK 1404644
Neurogene Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Neurogene Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 2, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202614:49 | Sep 22, 2026 | NGNE | Chief Executive Officer, Director | M · ExerciseLate 10d | $25.32 | +756 | 1,345,063 | +0% | $19K |